Sir-Spheres®

DEVICE2 trials

Sponsors

Thomas Jefferson University, Olivia Newton-John Cancer Research Institute

Conditions

Recurrent GlioblastomaRecurrent Glioblastoma IDH WildtypeStage IV Uveal Melanoma

Early Phase 1

Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma

Not yet recruitingNCT07712770

Olivia Newton-John Cancer Research InstituteRecurrent Glioblastoma, Recurrent Glioblastoma IDH Wildtype

Start: 2026-10-01End: 2028-11-01Target: 12Updated: 2026-07-17

Phase 2

SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver

CompletedNCT01473004

Thomas Jefferson UniversityStage IV Uveal Melanoma

Start: 2011-10-31End: 2024-12-31Updated: 2025-11-14

Related Papers

Abstract 4052: Cytokines and chemokines production after radiosphere treatment for uveal melanoma patients with hepatic metastases

Cancer Research2019-07-01

Abstract 4052: Cytokines and chemokines production after radiosphere treatment for uveal melanoma patients with hepatic metastases

Immunology2019-07-01

Radioembolization for treatment of uveal melanoma hepatic metastasis: Results of a phase II, single institution, prospective trial.

Journal of Clinical Oncology2018-05-201 citations